Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CRON
CRON logo

CRON Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Cronos Group Inc (CRON) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
2.840
1 Day change
52 Week Range
3.430
Analysis Updated At
2026/05/29
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

CRON is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock has some short-term technical strength, but the lack of recent news, no strong insider or hedge fund buying, no favorable proprietary buy signal, and weak near-term pattern expectations make this more of a wait-and-see name than an immediate purchase. If you want exposure, it is better to wait for a clearer pullback or a stronger fundamental catalyst.

Technical Analysis

CRON is in a short-term bullish technical setup: MACD histogram is positive and expanding, and moving averages are aligned bullishly with SMA_5 > SMA_20 > SMA_200. Price closed at 2.85, just above the pivot at 2.718 and near resistance at R1 2.844, which suggests the stock is already extended into resistance rather than offering an attractive entry. RSI_6 at 75.589 is elevated and points to near-term momentum that may be stretched. The pattern-based trend data is also not favorable for immediate upside, with a 60% chance of declines over the next day, week, and month.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Options sentiment is strongly bullish on the surface, with extremely low put-call ratios for both open interest and volume. Call open interest is far larger than put open interest, and option volume is heavily skewed toward calls. However, total options activity is still modest, so this is supportive but not enough by itself to override the stretched technical setup and lack of fundamental catalysts. IV is moderate-to-low relative to recent levels, which does not suggest an urgent event-driven re-pricing.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
2
Buy
9

Positive Catalysts

  • TD Securities raised its price target to C$5.50 from C$4.50 and kept a Buy rating, which is a constructive analyst catalyst. Options positioning is very bullish, suggesting traders are leaning optimistic. The stock also has a bullish moving-average structure and positive MACD momentum. There are no recent negative news items, and the broader market was positive on the day.

Neutral/Negative Catalysts

  • No news in the recent week means there is no fresh event-driven catalyst to support a near-term rerating. Hedge funds and insiders are both neutral, so there is no confirmation from smart-money activity. The technical setup is near resistance and RSI is elevated, while the historical candlestick-pattern signal points to a higher probability of short-term declines. There is also no recent congress trading data or politically influential buying to support the thesis.

Financial Performance

No usable latest-quarter financial snapshot was provided because of a data error, so there is not enough information here to assess current quarter revenue or earnings growth trends. Because the latest quarter season is unavailable, the fundamental read is incomplete. For a long-term beginner investor, that makes it harder to justify an immediate buy based on business performance alone.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent analyst trend is positive: TD Securities raised the price target to C$5.50 from C$4.50 and maintained a Buy rating on 2026-05-12. This is a bullish sign for Wall Street sentiment, but it is only one update and there is no broader analyst momentum provided. Overall pros view: improved target and buy rating. Cons view: limited analyst breadth in the data, no recent supporting news, and no evidence of accumulation from insiders or hedge funds.

Wall Street analysts forecast CRON stock price to fall
2 Analyst Rating
Wall Street analysts forecast CRON stock price to fall
1 Buy
1 Hold
0 Sell
Moderate Buy
Current: 2.840
sliders
Low
2.3
Averages
2.72
High
3.14
Current: 2.840
sliders
Low
2.3
Averages
2.72
High
3.14
TD Securities
NULL
to
Buy
maintain
AI Analysis
2026-05-12
Reason
TD Securities
Price Target
AI Analysis
2026-05-12
maintain
NULL
to
Buy
Reason
TD Securities raised the firm's price target on Cronos Group to C$5.50 from C$4.50 and keeps a Buy rating on the shares.
TD Securities
NULL -> Buy
initiated
$4.50
2026-02-24
Reason
TD Securities
Price Target
$4.50
2026-02-24
initiated
NULL -> Buy
Reason
TD Securities initiated coverage of Cronos Group with a Buy rating and C$4.50 price target. Cronos, which has "some of the most iconic Canadian cannabis brands on the market, is well-positioned to improve profitability as it scales the top-line with a lean operating cost base and leading cultivation practices, the analyst tells investors.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CRON
Unlock Now

People Also Watch